A carregar...
Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro–In Silico Model
Doxorubicin (Doxo) is the most effective chemotherapeutic agent for the treatment of breast cancer. However, resistance to Doxo is common. Adjuvant compounds capable of modulating mechanisms involved in Doxo resistance may potentiate the effectiveness of the drug. Resveratrol (Rsv) has been tested a...
Na minha lista:
| Publicado no: | Oxid Med Cell Longev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7654215/ https://ncbi.nlm.nih.gov/pubmed/33204396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5432651 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|